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By using the promoter-probe plasmid pIJ424, genomic DNA fragments of Actinomadura R39 were shown
to have promoter activity in Streptomyces lividans. The same 100-200-copy-number plasmid was used to
clone in S. lividans TK24, the gene that encodes the Actinomadura R39 ,-lactamase. Gene cloning resulted
in an amplified expression of the ,-lactamase when compared with the amounts of enzyme produced by the
original strain (1 mg versus 0.008 mg *litre of culture-').
INTRODUCTION
Actinomadura R39, isolated from an African soil and
initially designated 'Streptomyces R39', has a wall
peptidoglycan of the meso-diaminopimelic acid chemo-
type I (Ghuysen et al., 1973). It secretes during growth a
hypersensitive DD-peptidase/penicillin-binding protein
(Leyh-Bouille et al., 1972; Ghuysen et al., 1974; Frere
et al., 1974, 1980; Duez et al., 1981a,b) and very low
amounts of a f,-lactamase (Johnson et al., 1973; Duez
et al., 1982). Actinomadura spp. belong to the Order
Actinomycetales and possess a DNA G+ C content of
60-72 mol% (McClung, 1974), which is similar to that
of the genus Streptomyces. Given this similarity and the
fact that several genes encoding Streptomyces enzymes
have been cloned in a Streptomyces high-copy-number
vector-host system with amplification of the expressed
proteins (Dehottay et al., 1986; Duez et al., 1987; Lenzini
et al., 1987), the same strategy was used to overproduce
the Actinomadura R39 fl-lactamase.
MATERIALS AND METHODS
Bacterial strains and plasmids
Actinomadura R39 was from the local collection.
S. tividans TK24 (Hopwood et al., 1983) and S. tividans
M336, i.e. S. tividans TK24 bearing the promoter-probe
plasmid pIJ424 (Ward et al., 1986), were from the John
Innes Institute, Norwich, U.K.
Media and growth conditions
Cultures were grown at 28 °C, with vigorous orbital
shaking, in five different media: Difco brain-heart broth,
Merck peptone broth [as described by Leyh-Bouille et al.
(1971), except that peptone Merck 7213 was used],
Lennox broth (Lennox, 1955), L broth (Miller, 1972)
and E9 broth (Dehottay et al., 1986). R2YE agar
(Hopwood et al., 1985) was used for plating. Kanamycin
gradient plates were made with MMT medium (Katz
et al., 1983) as described (Ward et al., 1986). Spore
suspensions were prepared as described by Hopwood
et al. (1985).
Recombinant DNA techniques
Chromosomal and plasmid DNAs were prepared and
Streptomyces protoplasts were transformed as described
by Hopwood et al. (1985). DNA minipreparations were
made using the alkaline-lysis procedure of Birnboim &
Doly (1979) as modified by Kieser (1984). Treatments
with restriction endonucleases (from various commercial
sources), bacterial alkaline phosphatase (The Radio-
chemical Centre, Amersham; Bucks., U.K.) and phage-
T4 DNA ligase (Boehringer, Mannheim, Germany),
separation of digested DNAs by agarose-gel electro-
phoresis and elution of DNA fragments from the gels
were performed essentially as described in Maniatis et al.
(1982).
fl-Lactam compounds and other antibiotics
Nitrocefin was purchased from Oxoid Ltd., Basing-
stoke, Hants., U.K., and kanamycin from Sigma, St.
Louis, MO, U.S.A. The following compounds were gifts:
thiostrepton (from S. J. Lucania, E. R. Squibb and Sons,
New Brunswick, NJ, U.S.A.); phenoxymethylpenicillin
(from Dr. J. Vanderhaeghe, Rega Institute, Leuven,
Belgium); N-formimidoylthienamycin and cefoxitin
(from the Merck Institute for Therapeutic Research,
Rahway, NJ, U.S.A.); and cephaloridine (from E. Lilly
and Co., Indianapolis, IN, U.S.A.).
fI-Lactamase activity and enzyme units
Unless otherwise stated, nitrocefin (O'Callaghan et al.,
1972) was used as substrate and the tests were performed
in 50 mM-sodium phosphate, pH 7.0, containing 0.1 mg
of bovine serum albumin- ml-'. Routinely, 5-10 Isl
samples of enzyme were added to 450,u of 100 suM-
nitrocefin in buffer and incubated at 30 'C. One unit is
defined as the amount of enzyme hydrolysing 1 mol
of substrate/min at maximal velocity.
Kinetic parameters
Enzyme samples and various concentrations of /-
lactam substrates were incubated at 30 'C in 50 mm-
sodium phosphate, pH 7.0, and the absorbances of the
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solutions were monitored until stabilization, at 482 nm
for nitrocefin, 260 nm for cephaloridine and 235 nm for
phenoxymethylpenicillin. The reading frequency was
2 s-5 and the kinetic parameters were estimated as
described in De Meester et al. (1987). The enzyme
concentrations were such that completion of the reactions
was achieved in less than 5 min. Inactivation of the /,-
lactamases by cefoxitin and N-formimidoylthienamycin
was analysed on the basis of the simple model:
K k
E+I -Ir-E -I E-I*
where E is the enzyme, I is the ,I-lactam inactivator, K is
the dissociation constant, k+2 is the first-order rate
constant and E-I* is the acyl-enzyme. Two methods were
used. With cefoxitin, the enzyme and the inactivator
were incubated at 30 °C in buffer, and the residual
enzyme activity was measured, by using nitrocefin as
substrate, in samples removed after increasing incubation
times. With N-formimidoylthienamycin, the reporter-
substrate method (De Meester et al., 1987) was used. The
progressive decrease of the rate of hydrolysis of 100 uM-
nitrocefin was measured on ternary mixtures containing
the enzyme, the inactivator and nitrocefin.
Enzyme purification
Actinomadura R39 was grown for 65 h at 28 °C and
with strong aeration in a tank containing 200 litres of the
Merck peptone medium, and S. lividans CM3 was grown
for 96 h at 28 °C, in 60 1-litre flasks containing 500 ml of
the same peptone medium. After elimination of the
mycelium by centrifugation, the supernatant fluids were
stirred with DEAE-cellulose (10 g/litre) previously equi-
librated against 50 mM-sodium phosphate, pH 7.0, until
disappearance of the enzyme activity. The DEAE-cellu-
lose was washed exhaustively with 100 mM-Tris/HCl,
pH 7.2, containing 0.2 M-NaCl, until the absorbance of
the buffer at 280 nm was less than 0.2, and packed in
5 cm x 30 cm columns (for 350 g samples of ion-
exchanger). The enzymes were eluted with an NaCl gra-
dient made in 100 mM-Tris/HCl, pH 7.2, by dropwise
addition, at constant volume, of 1350 ml of 0.5 M-NaCl
in buffer to 600 ml of 0.2 M-NaCl in buffer. The active
fractions (total volume 800 ml) were concentrated
to 32 ml by ultrafiltration on a Diaflo UM10 membrane
(Amicon Corp., Danvers, MA, U.S.A.). The fl-lactamase
of S. lividans CM3 was further purified by three successive
runs on a 2.2 cm x 25 cm column of phenylboronic
acid-agarose type B (Cartwright & Waley, 1984). Elution
was carried out with 100 mM-Tris/HCI (pH 7.2)/0.5 M-
NaCl at a fow rate of 50 ml h-1 (Fig. 1). With the
Actinomadura R39 ,3-lactamase the third run was omitted
and replaced by an f.p.l.c. step on MonoQ HR5/5
(Pharmacia, Uppsala, Sweden).
Protein content and amino acid composition
The proteins were estimated by measuring the amounts
of amino groups available for dinitrophenylation after
hydrolysis by 6 M-HCl, at 110 °C (Duez et al., 1978). The
amino acid composition was established as described by
Joris et al. (1983).
Polyacrylamide-gel electrophoresis
Separation gel electrophoresis [70, (w/v) acrylamide,
pH 8.4] was run using 0.7 cm x 9.5 cm cylindrical gels
and a current of 5 mA/gel. After an overnight pre-run,
the samples were loaded and allowed to migrate until the
Bromophenol Blue marker reached the bottom of the
tube. Gel electrophoresis in the presence of SDS was
carried out as described by Laemmli & Favre (1973).
RESULTS AND DISCUSSION
Transcriptional efficacy of Actinomadura R39 promoters
in S. lividans
A portion (2 ,tg) of genomic DNA of Actinomadura
R39 was cleaved with restriction endonucleases BamHI,
BclJ and BglIlI respectively, and each digest was separately
ligated to 1 ,sg of promoter-probe plasmid pIJ424 (Fig.
2) previously cleaved with BgllI and treated with bacterial
alkaline phosphatase. The resulting ligation mixtures
were used to transform S. lividans TK24 protoplasts,
and the transformants were selected on R2YE agar
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Fig. 1. Purification of the S. Iividans CM3 fl-lactamase on a phenylboronic acid-agarose affinity column
Three successive runs, (a), (b) and (c), were performed. For details, see the Materials and methods section. Enzyme activity is
expressed in arbitrary units corresponding to an absorbance increase of 1.0 at 482 nm after 1 h of incubation. Such arbitrary
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Bg/l I
Fig. 2. Promoter-probe plasmid vector pIJ424 (Ward et al.,
1986)
pIJ424 uses the promoterless aminoglycoside phospho-
transferase gene (aphII) of transposon Tn5 as the indicator
for promoter activity. There is a unique BglII site located
downstream ofthe major terminator (ter) ofthe Escherichia
coli phage fd (so that readthrough from upstream vector
promoters is prevented) and upstream of a ribosome-
binding site, an in-frame stop codon and the start codon of
the aphll gene. Insertion of a promoter-containing DNA
fragment in the BglII site results in the expression of
kanamycin resistance in a suitable host such as S. lividans
TK24. pIJ424 is a derivative of the pIJIO1 replicon (Kieser
et al., 1982); it occurs in a 100-200 copy number per
chromosome (Ward et al., 1986) and also contains the
thiostrepton-resistance marker (tsr).
1 4 T.....
et al., 1985). Transformation rates (numbers of trans-
formants
-c/g of plasmid'1) ranged from 1.4 to 3.0 x I04.
Spore suspensions of thiostrepton-resistant trans-
formants were streaked on kanamycin gradient (from 0
to 250 ,ug * ml-') plates. Growth was frequently observed
up to half way on the gradient (Fig. 3). S. lividans M336,
which contained the original pIJ424, served as control;
few colonies grew only at the origin of the gradient. The
plasmid DNAs of 30 kanamycin-resistant clones were
analysed by agarose-gel electrophoresis. They all had an
increased molecular mass when compared with that of
pIJ424. In all likelihood these plasmids had acquired
Actinomadura R39 genomic DNA fragments that con-
tained promoter regions, thus permitting expression of
the promoterless aphll gene of pIJ424.
fl-Lactamase-producing S. lividans CM3
Since Actinomadura R39 promoters were recognized
and effectively utilized by S. lividans, thiostrepton-
resistant transformants having the capacity of producing
an extracellular fl-lactamase were selected by nitrocefin
test on R2YE agar plates (Dehottay et al., 1986). Nine of
them produced the desired activity; seven originated
from the Bcll library, two from the BamHI library and
none from the BglIl library. Their ,-lactamase-producing
capacity was tested in five different growth media (see the
Materials and methods section). S. lividans CM3, from
the BamHI library, was the best ,-lactamase producer.
Its 8.1 kb plasmid pDML150 had no Bglll site. The
occurrence of hybrid BglII/BamHI sites prevented the
1.8 kb insert from being isolated.
Maximal level of 8-lactamase secretion by S. lividans
CM3, i.e. - 1 mg of enzyme- litre of culture-1, occurred





Fig. 3. Growth of S. lividans transformants on kanamycin gradient (0-250 pg. ml-l) plates
T, S. lividans M336 (TK24+pIJ424). 1-14, S. lividans strains transformed with the ligation mixtures described in the text.
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Table 2. Amino acid composition of the Actinomadura R39 and
S. lividans CM3 p-lactamases
Composition (mol/100 mol)























































* Data from Duez et al. (1982).
level was 100-fold higher than that observed with the
original Actinomadura R39 strain (~ 0.008 mg of en-
zyme litre of culture-') grown under identical and op-
timal conditions. A similar amplified expression of the ,-
lactamases of Streptomyces albus G (Dehottay et al.,
1986) and Streptomyces cacaoi (Lenzini et al., 1987) had
been observed after gene cloning in S. lividans via pIJ702
(30 and 40 mg of enzyme- litre of culture-1 as against 0.5
and 1.5 mg of enzyme litre of culture-1 for the original
strains).
Actinomadura R39 and S. lividans CM3 fl-lactamases
Actinomadura R39 and S. lividans CM3 were grown,
and the secreted ,-lactamases were purified (see the
Materials and methods section). The last purification
step yielded fractions which, irrespective of the producing
strain, had a constant specific enzyme activity of about
1200 units * mg of protein-', using nitrocefin as substrate.
Table 1 gives the enzyme recoveries and enrichments.
The Actinomadura R39 and S. lividans CM3 ,-
lactamases were co-eluted by f.p.l.c. on MonoQ HR5/5.
Elution occurred at 0.51 M-NaCl. Upon polyacrylamide-
gel electrophoresis under non-denaturing conditions,
they migrated 7.8 cm towards the anode as a single
protein band. Upon SDS/polyacrylamide-gel electro-
phoresis, they also migrated as a single protein band with
an apparent relative molecular mass of 55-57 kDa.
Upon filtration on Sephadex G-100 in 50 mM-sodium
phosphate (pH 7.2)/0.5 M-NaCl, they exhibited an
elution coefficient value which, by reference to standard
proteins, indicated an apparent molecular mass of
38.5 kDa. Great variations in the estimated molecular
mass of the Actinomadura R39 ,-lactamase prepared as
described by Duez et al. (1982) had been observed. That
former preparation contained about 100% (w/w) of a
polydeoxyribonucleotide material, apparently in the form
of a stable complex. Though the enzyme preparations
obtained in the course of the present study lacked
this contaminating material, SDS/polyacrylamide-gel
electrophoresis and molecular sieving failed to yield con-
sistent molecular-mass values. The reason for these
discrepancies is not understood. Nucleotide sequencing
(S. Houba, S. Willem, C. Duez, C. Molitor & J. Dusart,
unpublished work) revealed that the cloned S. lividans
CM3 ,J-lactamase gene codes for a 304-amino-acid
polypeptide, i.e. a 276-amino-acid mature protein of
29.27 kDa. Within the limits of experimental errors, the
S. lividans CM3 ,-lactamase and the original Actino-
madura R39 ,3-lactamase (Duez et al., 1982) have the
same amino acid composition (Table 2).
The Actinomadura R39,8-lactamase is a wide-spectrum
enzyme, penicillins and A3-cephalosporins being either
good or poor substrates. The kinetic parameters of
hydrolysis of three different fl-lactam antibiotics by the
Actinomadura R39 and S. lividans CM3 fl-lactamases
prepared and purified as described above were re-
determined (Table 3). Both enzymes behaved similarly.
The two fl-lactamase preparations also reacted similarly
with two different ,-lactamase inactivators (Table 4).
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Table 3. Kinetic parameters of Actinomadura R39 and S. fividans CM3 II-lactamases
Each value represents the average (±S.D.) of at least three measurements.
Enzyme Km (/,M) VMax.*
Concentration quantity






















* V.ax. values are expressed as a percentage of that with nitrocefin (= 1200,mol min-' mg of protein-1).
Table 4. Kinetic parameters of the inactivation of the Actinomadura R39 and S. liuvidans CM3 8-lactamases by II-lactam compounds
Each value represents the average (± S.D.) of at least three measurements.
Value
Kinetic












With cefoxitin, the rate of inactivation did not vary
between 20 and 60 mm, indicating a K value of much
less than 20 mm. With N-formimidoylthienamycin, the
values of k1, where
k k+21C]
= [C] +K
were measured at concentrations ranging from 0.3 to
1.5 uM. The individual values of k+2 and K were derived
from plots 1 /k, versus 1/[C], where [C] is the con-
centration of formimidoylthienamycin.
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